Serology+ | n | Prevalence % [95% IC] | Age (±SD) | Modal class | Serology-(±SD) | p |
HIV | 65 | 4.6 [3.7 - 5.9] | 71.9 (±9.5) | [60 - 70] 58% | 66.4 (±11.4) | 0.0016 |
HBV | 40 | 2.9 [2.1 - 3.9] | 73.7 (±14.5) | [60 - 70] 63% | 66.5 (±11.2) | 0.0154 |
HCV | 165 | 11.8 [10.2 - 13.6] | 83.5 (±6.1) | [80 - 90] 74% | 64.4 (±9.9) | <0.001 |
Co-infections | 17 | 1.2 [0.8 - 1.9] | 92.3 (±13.8) | [80 - 90] 41% | 66.4 (±9.9) | <0.001 |
HIV/HBV | 2 | 0.14 [0.04 - 0.52] | 79.0 (±0.0) | [70 - 80] 100% | 66.6 (±11.4) | 0.0555 |
HIV/HCV | 8 | 0.57 [0.29 - 1.12] | 90.6 (±7.0) | [90 - 100] 63% | 66.5 (±11.2) | <0.001 |
HBV/HCV | 7 | 0.50 [0.24 - 1.03] | 98.0 (±18.7) | [80 - 90] 57% | 66.5 (±11.1) | <0.001 |
Total | 253 | 18 [16.1 - 20.1] | 78.4 (±9.3) | [80 - 90] 48% | 64.1 (±10.1) | <0.001 |